BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25809059)

  • 1. The Implementation of the Bethesda System for Reporting Thyroid Cytopathology Improves Malignancy Detection Despite Lower Rate of Thyroidectomy in Indeterminate Nodules.
    Hirsch D; Robenshtok E; Bachar G; Braslavsky D; Benbassat C
    World J Surg; 2015 Aug; 39(8):1959-65. PubMed ID: 25809059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
    Lim JXY; Nga ME; Chan DKH; Tan WB; Parameswaran R; Ngiam KY
    Thyroid; 2018 Apr; 28(4):511-521. PubMed ID: 29596039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of repeat fine needle aspiration in the management of indeterminate thyroid nodules.
    Jooya A; Saliba J; Blackburn A; Tamilia M; Hier MP; Mlynarek A; Forest VI; Rochon L; Florea A; Wang H; Payne RJ
    J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):51. PubMed ID: 27756425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indeterminate nodules by the Bethesda system for reporting thyroid cytopathology in Israel: Frequency, and risk of malignancy after reclassification of follicular thyroid neoplasm with papillary-like features.
    Rosenblum RC; Shtabsky A; Marmor S; Trejo L; Yaish I; Barnes S; Yehuda M; Stern N; Silman Z; Tordjman KM
    Eur J Surg Oncol; 2019 Jul; 45(7):1182-1187. PubMed ID: 30928335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
    Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
    Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of the Bethesda terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: a report from a reference center in Turkey.
    Ozluk Y; Pehlivan E; Gulluoglu MG; Poyanli A; Salmaslioglu A; Colak N; Kapran Y; Yilmazbayhan D
    Int J Surg Pathol; 2011 Dec; 19(6):761-71. PubMed ID: 21791482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions.
    Crowe A; Linder A; Hameed O; Salih C; Roberson J; Gidley J; Eltoum IA
    Cancer Cytopathol; 2011 Oct; 119(5):315-21. PubMed ID: 21751427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
    Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
    Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
    Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
    Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
    BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients.
    Lew JI; Snyder RA; Sanchez YM; Solorzano CC
    J Am Coll Surg; 2011 Jul; 213(1):188-94; discussion 194-5. PubMed ID: 21601489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: Experience of a Tertiary Care Referral Center.
    Heider A; Arnold S; Jing X
    Arch Pathol Lab Med; 2020 Apr; 144(4):473-477. PubMed ID: 31403334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
    Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
    Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.
    Tang AL; Falciglia M; Yang H; Mark JR; Steward DL
    Thyroid; 2017 Aug; 27(8):1077-1082. PubMed ID: 28657511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
    Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
    Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
    Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R
    Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Kuru B; Atmaca A; Tarim IA; Kefeli M; Topgul K; Yoruker S; Elmali M; Danaci M
    Eur J Surg Oncol; 2016 Jan; 42(1):87-93. PubMed ID: 26527545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions.
    Rabaglia JL; Kabbani W; Wallace L; Holt S; Watumull L; Pruitt J; Snyder WH; Nwariaku FE
    Surgery; 2010 Dec; 148(6):1267-72; discussion 1272-3. PubMed ID: 21134560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Implementation of the Bethesda system for reporting the thyroid cytopathology: study on 5 729 cases from a cancer center].
    Guo HQ; Zhao H; Cao J; Zhao LL; Sun Y; Wang C; Zhang ZH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Mar; 55(3):258-262. PubMed ID: 32268696
    [No Abstract]   [Full Text] [Related]  

  • 20. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
    Tepeoğlu M; Bilezikçi B; Bayraktar SG
    Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.